SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
40 hedge funds and large institutions have $72.5M invested in Sinovac Biotech, Ltd in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less call options, than puts
Call options by funds: $1K | Put options by funds: $2K
Holders
40
Holding in Top 10
–
Calls
$1K
Puts
$2K
Top Buyers
| 1 | +$3.7M | |
| 2 | +$1.36M | |
| 3 | +$351K | |
| 4 |
Two Sigma Investments
New York
|
+$279K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$167K |
Top Sellers
| 1 | -$4.08M | |
| 2 | -$2.67M | |
| 3 | -$802K | |
| 4 |
ProShare Advisors
Bethesda,
Maryland
|
-$216K |
| 5 |
Millennium Management
New York
|
-$80.3K |